NMPA Approval

Amisulpride Oral Solution

Approval Number

国药准字HJ20250043

Company

syri limited

Registration Date

April 15, 2025

Drug Information

Generic Name

氨磺必利口服溶液

Dosage Form

口服溶液剂

Strength

60ml:6g

Drug Type

化学药品

Registration Date

April 15, 2025

Expiry Date

April 14, 2030

Company Information

Applicant Company

Company Name

syri limited

Company Address

UNIT 4, BRADFIELD ROAD, RUISLIP, HA4 0NU, UNITED KINGDOM

Manufacturing Company

Company Name

syri limited

Company Address

UNIT 4, BRADFIELD ROAD, RUISLIP, HA4 0NU, UNITED KINGDOM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.